{
  "id": "6e7324c0713e5455",
  "title": "ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA\u00ae Plus CAR - NK , Chemo - Free Therapy",
  "description": "20260123T170000Z",
  "content": "",
  "source": "rutlandherald.com",
  "source_url": "https://www.rutlandherald.com/news/business/immunitybio-reports-median-overall-survival-not-yet-reached-and-lymphopenia-reversed-in-recurrent-glioblastoma-patients/article_dff8a8b4-834f-5354-b178-062aa024a8e3.html",
  "published_at": "20260123T170000Z",
  "fetched_at": "2026-01-24T00:23:07.160904+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.rutlandherald.com/news/business/immunitybio-reports-median-overall-survival-not-yet-reached-and-lymphopenia-reversed-in-recurrent-glioblastoma-patients/article_dff8a8b4-834f-5354-b178-062aa024a8e3.html",
    "url_mobile": "",
    "title": "ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA\u00ae Plus CAR - NK , Chemo - Free Therapy",
    "seendate": "20260123T170000Z",
    "socialimage": "https://bloximages.chicago2.vip.townnews.com/rutlandherald.com/content/tncms/assets/v3/editorial/0/41/04121a31-b869-5ca1-90a6-5322fe950d0a/6973637891475.image.jpg?crop=292%2C292%2C322%2C0",
    "domain": "rutlandherald.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}